You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 4, April 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Feature
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Neonatology and Infant Care
 •Picture of the Month
 •Dermatologic Disorders, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Picture of the Month—Diagnosis


Arch Pediatr Adolesc Med. 2008;162(4):384.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Denouement and Discussion: Urticaria Pigmentosa

Mastocytosis is a disorder characterized by mast cell accumulation in tissue most commonly in the skin, and it may also affect the bone marrow, gastrointestinal tract, skeletal system, liver, spleen, and lymph nodes. A World Health Organization consensus group1 recently divided the disease into 7 forms: cutaneous mastocytosis, indolent systemic mastocytosis, systemic mastocytosis with an associated hematologic non–mast cell lineage, aggressive systemic mastocytosis, mast cell leukemia, mast cell sarcoma, and extracutaneous mastocytoma. Systemic mastocytosis is mostly an adult phenomenon.

CLINICAL FEATURES

Urticaria pigmentosa (UP), the most common type of mastocytosis, is defined by multiple red-brown hyperpigmented macules, papules, or nodules.2 The most recent studies estimate its incidence to be 1 in 150 000.1 In 55% of patients, UP begins before age 2 years, and in 10% of patients it occurs between ages 2 and 15 years. Onset for the remaining 35% of patients occurs between ages 20 and 40 years. Urticaria pigmentosa most . . . [Full Text of this Article]

DIAGNOSIS

TREATMENT


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Picture of the Month—Quiz Case
Amir A. Bajoghli and Cassie M. Blankenship
Arch Pediatr Adolesc Med. 2008;162(4):383.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.